FOXM1 and neoplasm: The upregulation and activation of FOXM1 can lead to a variety of tumor-associated phenotypes such as cell proliferation, tumor stem cells, drug resistance, invasion, metastasis, and angiogenesis [30–33], which have been reported as top-level gene expression biomarkers with poor prognosis [34].